F18.288
Inhalant dependence with other inhalant-induced disorder
Clinical Classification Guidelines
Inclusion Terms
- Inhalant use disorder, moderate, with inhalant-induced mild neurocognitive disorder
- Inhalant use disorder, severe, with inhalant-induced mild neurocognitive disorder
Medical Intelligence & Overview
Inhalant dependence with other inhalant-induced disorder, coded as F18.288 in the ICD-10 system, refers to a condition where a person relies heavily on inhaled substances that lead to additional health issues. This includes a moderate to severe dependence on inhalants, accompanied by a mild form of neurocognitive impairment induced by inhalant use. Inhalant use disorder can significantly impact an individual's mental and physical health, requiring understanding and appropriate management.
Causes & Symptoms
Clinical Causes: Frequent and prolonged inhalant use, leading to physical dependence Psychological factors such as stress or the desire to escape from difficult life circumstances Availability of inhalant substances like solvents, gases, or aerosols Peer pressure or social environment encouraging inhalant use Underlying mental health conditions that increase vulnerability to substance use
Key Symptoms: Craving or strong desire to use inhalants Inability to control or reduce inhalant use despite negative effects Neglect of responsibilities at work, school, or home Use of inhalants in hazardous situations, such as while driving Tolerance, needing increased amounts to achieve the desired effect Withdrawal symptoms when not using inhalants Cognitive impairments, such as memory issues or difficulty concentrating Physical signs like chemical odors on breath or clothing, dizziness, or coordination problems
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive evaluation by a healthcare professional, including a detailed history of inhalant use, assessment of dependence symptoms, and cognitive testing. Medical professionals may use standardized questionnaires and clinical criteria aligned with ICD-10 guidelines to determine the severity and presence of neurocognitive impairment. Laboratory tests may be conducted to detect inhalant-related substances or health effects.
Treatment Protocols: Detoxification to safely manage withdrawal symptoms under medical supervision Psychosocial therapies such as counseling, cognitive-behavioral therapy (CBT), or family therapy Support groups to provide peer support and encouragement Addressing co-occurring mental health issues like anxiety or depression Monitoring and managing physical health problems related to inhalant use Long-term follow-up to prevent relapse and support recovery
Clinical Advice & FAQs
Billing Guidance
Is F18.288 a billable ICD-10 code?
Yes, F18.288 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.288?
Clinical documentation must specify the nature of Inhalant dependence with other inhalant-induced disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
